Atrium Therapeutics
RNA
#4419
Rank
NZ$4.17 B
Marketcap
NZ$26.50
Share price
-6.47%
Change (1 day)
-35.85%
Change (1 year)

Atrium Therapeutics (RNA) Fails to deliver data

Key failure to deliver metrics for Atrium Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atrium Therapeutics (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atrium Therapeutics (RNA) - since 2026

Volume in USD (price x number of shares), data since 2026

Atrium Therapeutics (RNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$18.42 M